ACE2 and chronic obstructive pulmonary disease: Current results also match our previous findings with increased ACE2 expression in smokers and COPD [5,7,31], which conclusively indicates that an increased expression of ACE2, TMPRSS2, and Furin makes these patients extremely vulnerable to SARS-CoV-2 infections.